ALKEM LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,245 INR | +1.18% |
|
+2.53% | +1.01% |
| 04-16 | Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak | CI |
| 03-28 | Alkem Laboratories Forms Subsidiary for Medical Devices Business | MT |
Presenter SpeechBasudeo Singh (Executives)Good morning, ladies and gentlemen. I welcome all th...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Alkem Laboratories Limited is an India-based company, which is engaged in the pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The Company offers its products across various therapeutic areas, such as Anti Infective, Dermatology, Diabetology, Cardiology, Gastroenterology, Osteoporosis, Rheumatology, central nervous system (CNS), Oncology, Urology, Gynecology, and Vitamins, Mineral and Nutrition. Its product range includes Rx Products, Alkem Generics and OTC Product. The Companyâs product portfolio includes brands, such as Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo and Ondem. The Company operates through a segment, Pharmaceuticals. It has approximately 21 manufacturing facilities at multiple locations in India and the United States. The Company has approximately 800 brands and operates in 40 countries.
Sector
Pharmaceuticals
Calendar
2024-05-29
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
5,247
INR
Average target price
5,184
INR
Spread / Average Target
-1.20%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +31.37% | 588B | |
| -2.78% | 364B | |
| +20.54% | 326B | |
| +5.57% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +11.04% | 167B | |
| +0.27% | 161B |
- Stock Market
- Equities
- ALKEM Stock
- ALKEM Stock
- News Alkem Laboratories Limited
- Transcript : Alkem Laboratories Limited - Shareholder/Analyst Call